• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种超敏前列腺特异性抗原检测方法用于前列腺癌根治术后残留癌早期检测的比较。

A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy.

作者信息

Prestigiacomo A F, Stamey T A

机构信息

Department of Urology, Stanford University School of Medicine, California 94305-5118.

出版信息

J Urol. 1994 Nov;152(5 Pt 1):1515-9. doi: 10.1016/s0022-5347(17)32459-x.

DOI:10.1016/s0022-5347(17)32459-x
PMID:7523709
Abstract

The Yang Pros-Check, Abbott IMx, Tosoh AIA-PACK PA and Nichols Institute reference laboratory prostate specific antigen (PSA) assays were compared in 30 patients (138 sera) known to have no residual prostate cells. The mean + 3 standard deviations of these sera was used to define a level of PSA that would indicate residual cancer. This residual cancer detection limit for each of the 4 assays is 0.06, 0.01, 0.07 and 0.05 ng./ml., respectively, but the 0.01 level for the IMx assay is an artifact caused by setting the zero calibrator too high. All 4 assays were then used to compare the number of days from radical prostatectomy to the detection of residual cancer in 23 cases (211 sera) that ultimately failed radical prostatectomy. The Yang, Tosoh and Nichols Institute assays were all similar, with an average of 569 to 589 days. The Abbott IMx assay was relatively insensitive in detecting the first appearance of PSA after radical prostatectomy (average 821 days) and it showed the earliest detection among the 4 assays in only 1 of 23 patients.

摘要

在30名已知无残留前列腺细胞的患者(138份血清)中,对杨Pros-Check、雅培IMx、东曹AIA-PACK PA和尼科尔斯研究所参考实验室的前列腺特异性抗原(PSA)检测方法进行了比较。这些血清的均值加3个标准差被用于定义一个可提示残留癌的PSA水平。这4种检测方法各自的残留癌检测限分别为0.06、0.01、0.07和0.05纳克/毫升,但IMx检测法的0.01水平是由于零校准物设定过高导致的假象。随后,使用所有4种检测方法比较了23例(211份血清)最终根治性前列腺切除术失败的患者从根治性前列腺切除到检测到残留癌的天数。杨、东曹和尼科尔斯研究所的检测方法都相似,平均为569至589天。雅培IMx检测法在检测根治性前列腺切除术后PSA的首次出现方面相对不敏感(平均821天),在23例患者中只有1例其检测时间在4种检测方法中最早。

相似文献

1
A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy.四种超敏前列腺特异性抗原检测方法用于前列腺癌根治术后残留癌早期检测的比较。
J Urol. 1994 Nov;152(5 Pt 1):1515-9. doi: 10.1016/s0022-5347(17)32459-x.
2
Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.通过超灵敏前列腺特异性抗原检测法早期发现前列腺癌根治术后的残留前列腺癌。
J Urol. 1993 Apr;149(4):787-92. doi: 10.1016/s0022-5347(17)36208-0.
3
Comparison of four automated prostate-specific antigen assays for detection of recurrence after radical prostatectomy.四种用于检测前列腺癌根治术后复发的前列腺特异性抗原自动化检测方法的比较。
Urology. 1997 Jun;49(6):894-7. doi: 10.1016/s0090-4295(97)00090-3.
4
Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay.
Urology. 1996 Jun;47(6):878-81. doi: 10.1016/S0090-4295(96)00050-7.
5
The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.“超敏”前列腺特异性抗原检测法在根治性前列腺切除术后生化复发检测中的应用。
Br J Urol. 1996 Mar;77(3):418-22. doi: 10.1046/j.1464-410x.1996.91017.x.
6
Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.
Anticancer Res. 1999 Jul-Aug;19(4A):2641-4.
7
Ultrasensitive assay of prostate-specific antigen for early detection of residual cancer after radical prostatectomy.用于前列腺癌根治术后残留癌早期检测的前列腺特异性抗原超敏检测法。
Int J Urol. 1998 Nov;5(6):550-5. doi: 10.1111/j.1442-2042.1998.tb00411.x.
8
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.422例前列腺癌根治术后患者随访中前列腺特异性抗原的超敏检测
J Urol. 1999 Apr;161(4):1206-11.
9
Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.采用超灵敏化学发光前列腺特异性抗原检测法早期发现复发性前列腺癌。
Urology. 1997 Oct;50(4):573-9. doi: 10.1016/S0090-4295(97)00251-3.
10
The periurethral glands do not significantly influence the serum prostate specific antigen concentration.尿道周腺对血清前列腺特异性抗原浓度无显著影响。
J Urol. 1996 May;155(5):1658-60.

引用本文的文献

1
Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review.前列腺特异性抗原作为早期复发性前列腺癌患者的超敏生物标志物:我们应降至多低?一项系统评价。
Biomedicines. 2024 Apr 8;12(4):822. doi: 10.3390/biomedicines12040822.
2
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.大豆分离蛋白补充对根治性前列腺切除术后前列腺癌生化复发的影响:一项随机试验。
JAMA. 2013 Jul 10;310(2):170-8. doi: 10.1001/jama.2013.7842.
3
The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy.
错配修复蛋白的高表达是根治性前列腺切除术后生化复发的一个预测指标。
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):57-64. doi: 10.1158/1055-9965.EPI-08-0377.
4
The effective management of biochemical recurrence in patients with prostate cancer.前列腺癌患者生化复发的有效管理。
Rev Urol. 2005;7 Suppl 5(Suppl 5):S29-36.
5
Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.前列腺特异性抗原(PSA)的抗原决定簇及针对不同形式PSA的检测方法的开发
Br J Cancer. 1997;75(6):789-97. doi: 10.1038/bjc.1997.142.